normal starting dose of semaglutide Dosing GLP-1s | AgelessRx
Description
Lancet 398(10313):18111824
The 5% of people Americans currently on GLP-1 receptor agonist drugs could easily account for more than 5% of American sugar consumption
Imagine injecting a medication designed to improve your health, only to introduce harmful bacteria into your systemits counterproductive to the treatments purpose
This allows distinction between short term effect under up titration and more sustained impacts of GLP-1 RA, DPP-4 inhibitors or SGLT-2 inhibitors
The British Journal of Surgery
It's not yet established whether GLP-1 RAs will benefit people without those risk factors in preventing dementia
